International Journal of Antimicrobial Agents
Volume 36, Issue 3 , Pages 239-242, September 2010

Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance

  • S. Aathithan

      Affiliations

    • Corresponding Author InformationCorresponding author at: King's College London, Department of Infectious Diseases, Westminster Bridge Road, 5th Floor, North Wing, St. Thomas’ Hospital, London SE1 7EH, United Kingdom. Tel.: +44 207 188 3127; fax: +44 207 928 0730.
  • ,
  • G.L. French

King's College London, Department of Infectious Diseases, Division of Immunology, Infection and Inflammatory Diseases, School of Medicine, St Thomas’ Hospital, London SE1 7EH, UK

Received 16 February 2010; accepted 27 April 2010. published online 14 June 2010.

Abstract 

We investigated hypermutability in Klebsiella pneumoniae and its association with ciprofloxacin resistance and mutations in the quinolone resistance-determining region (QRDR). Sixty-four strains of K. pneumoniae isolated in London, UK, between 1995 and 2002 with widely differing ciprofloxacin minimum inhibitory concentrations (MICs) and known gyrA and parC sequences were tested for mutation frequencies by selection with rifampicin. Only three hypermutable (frequency ≥10−6) strains were identified, with ciprofloxacin MICs of 0.25μg/mL, 8μg/mL and 64μg/mL. There was no relationship between hypermutation and the ciprofloxacin MIC or QRDR mutations. Screening selected strains with streptomycin did not reveal any hypermutators, and screening with ciprofloxacin identified only two of the three hypermutators identified by rifampicin. Hypermutation in K. pneumoniae is uncommon and does not contribute to accumulation of QRDR mutations or directly to ciprofloxacin resistance.

Keywords: Enterobacteriaceae, Klebsiella, Random hypermutation, Fluoroquinolone resistance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Part of this study was presented at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 16–19 May 2009, Helsinki, Finland (abstract P1481).

PII: S0924-8579(10)00198-6

doi:10.1016/j.ijantimicag.2010.04.010

International Journal of Antimicrobial Agents
Volume 36, Issue 3 , Pages 239-242, September 2010